| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |